This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Chromadex, The Potential "Game Changer" In Patient Dependency Of The Multi-Billion Dollar Pharmaceutical Industry

CHICAGO, Nov. 8, 2012 /PRNewswire/ - Imagine a world where organic vitamins and dietary supplements prevented the use of engineered medication. Where patients could naturally treat medical problems without adhering to the many various side effects of pharmaceutical drugs. This is a notion that could appeal to the millions of Americans dealing with the defects of routine prescription drug consumption.

Natural compounds such as pterostilbene and resveratrol have been tested to assist in treating ailing conditions such as high blood pressure and high cholesterol. Chromadex is a natural product company that examines these organic compounds in order to discover any medical use for them. Once they do, they create a patent on how to manufacture the compound with obtaining the rights of both the health claims and the patent itself. These ingredients are sold under the dietary supplement category through retail and other traditional marketing outlets.

The 13-year old company has already tested thousands of products, creating over a dozen patents marketed across the world. Its most recent branded patent, pTeroPure derives from pterostilbene, an organic antioxidant compound found in blueberries.  So far, pTeroPure has shown breakthrough potential for Chromadex. A clinical study conducted by the University of Mississippi Medical Center indicates that its primary ingredient, pterostilbene significantly reduces blood pressure in adults, without posing any side effects.

University of Mississippi Medical Center PharmD Cardiometabolic Clinic Coordinator Dr. Daniel Riche reported that the 8 week study of the organic compound presented no significant safety concerns from the 80 people tested in the trial. In addition to safety, the study tested the effects of high blood pressure and cholesterol.  Although the results on cholesterol were neutral, Riche mentioned that its effect on the 55 percent of subjects suffering from high blood pressure, displayed mercury point reductions by up to 7 percent.

"We put it into patients who would be considered to have elevated cholesterol levels and and regular blood pressure levels. Although we did not put it with patients with elevated blood pressure, it still reduced blood pressure. So of course the next step is to put it into patients who have elevated blood pressure on multiple medications," said Riche.

1 of 4

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs